DOMH
Price
$5.55
Change
-$0.35 (-5.93%)
Updated
Jun 27 closing price
Capitalization
81.27M
50 days until earnings call
ENTA
Price
$7.50
Change
-$0.01 (-0.13%)
Updated
Jun 27 closing price
Capitalization
160.32M
42 days until earnings call
Interact to see
Advertisement

DOMH vs ENTA

Header iconDOMH vs ENTA Comparison
Open Charts DOMH vs ENTABanner chart's image
Dominari Holdings
Price$5.55
Change-$0.35 (-5.93%)
Volume$168.56K
Capitalization81.27M
Enanta Pharmaceuticals
Price$7.50
Change-$0.01 (-0.13%)
Volume$234.4K
Capitalization160.32M
DOMH vs ENTA Comparison Chart in %
Loading...
DOMH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DOMH vs. ENTA commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DOMH is a Buy and ENTA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (DOMH: $5.55 vs. ENTA: $7.50)
Brand notoriety: DOMH and ENTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DOMH: 52% vs. ENTA: 152%
Market capitalization -- DOMH: $81.27M vs. ENTA: $160.32M
DOMH [@Biotechnology] is valued at $81.27M. ENTA’s [@Biotechnology] market capitalization is $160.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DOMH’s FA Score shows that 0 FA rating(s) are green whileENTA’s FA Score has 1 green FA rating(s).

  • DOMH’s FA Score: 0 green, 5 red.
  • ENTA’s FA Score: 1 green, 4 red.
According to our system of comparison, ENTA is a better buy in the long-term than DOMH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DOMH’s TA Score shows that 5 TA indicator(s) are bullish while ENTA’s TA Score has 4 bullish TA indicator(s).

  • DOMH’s TA Score: 5 bullish, 4 bearish.
  • ENTA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, DOMH is a better buy in the short-term than ENTA.

Price Growth

DOMH (@Biotechnology) experienced а -2.37% price change this week, while ENTA (@Biotechnology) price change was +4.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

DOMH is expected to report earnings on Aug 19, 2025.

ENTA is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENTA($160M) has a higher market cap than DOMH($81.3M). DOMH YTD gains are higher at: 486.690 vs. ENTA (30.435). DOMH has higher annual earnings (EBITDA): -40.28M vs. ENTA (-87.12M). ENTA has more cash in the bank: 193M vs. DOMH (18.9M). DOMH has less debt than ENTA: DOMH (2.92M) vs ENTA (58.7M). ENTA has higher revenues than DOMH: ENTA (64.5M) vs DOMH (24.9M).
DOMHENTADOMH / ENTA
Capitalization81.3M160M51%
EBITDA-40.28M-87.12M46%
Gain YTD486.69030.4351,599%
P/E RatioN/AN/A-
Revenue24.9M64.5M39%
Total Cash18.9M193M10%
Total Debt2.92M58.7M5%
FUNDAMENTALS RATINGS
DOMH vs ENTA: Fundamental Ratings
DOMH
ENTA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
3441
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DOMH's Valuation (72) in the null industry is in the same range as ENTA (96) in the Biotechnology industry. This means that DOMH’s stock grew similarly to ENTA’s over the last 12 months.

DOMH's Profit vs Risk Rating (100) in the null industry is in the same range as ENTA (100) in the Biotechnology industry. This means that DOMH’s stock grew similarly to ENTA’s over the last 12 months.

DOMH's SMR Rating (98) in the null industry is in the same range as ENTA (98) in the Biotechnology industry. This means that DOMH’s stock grew similarly to ENTA’s over the last 12 months.

DOMH's Price Growth Rating (34) in the null industry is in the same range as ENTA (41) in the Biotechnology industry. This means that DOMH’s stock grew similarly to ENTA’s over the last 12 months.

ENTA's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for DOMH (100) in the null industry. This means that ENTA’s stock grew significantly faster than DOMH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DOMHENTA
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
65%
Momentum
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
66%
MACD
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
75%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 20 days ago
70%
Declines
ODDS (%)
N/A
Bearish Trend 14 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
DOMH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AFSIN13.360.01
+0.04%
AmTrust Financial Services, Inc.
SCVPY4.90N/A
N/A
Siam Cement Public Co. Ltd.
VETTF2.08N/A
N/A
Vector Ltd.
ITMSF1.67-0.03
-1.85%
Intermap Technologies Corp.
QNCCF1.20-0.16
-11.50%
Quantum eMotion Corp.

DOMH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DOMH has been loosely correlated with EDSA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if DOMH jumps, then EDSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DOMH
1D Price
Change %
DOMH100%
-5.93%
EDSA - DOMH
35%
Loosely correlated
+5.03%
FHTX - DOMH
32%
Poorly correlated
-0.41%
MBRX - DOMH
29%
Poorly correlated
-3.04%
ENTA - DOMH
29%
Poorly correlated
-0.13%
SWTX - DOMH
28%
Poorly correlated
-0.02%
More

ENTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with ALEC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then ALEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
-0.13%
ALEC - ENTA
42%
Loosely correlated
-1.33%
BEAM - ENTA
40%
Loosely correlated
-1.98%
ADCT - ENTA
38%
Loosely correlated
+0.37%
PRME - ENTA
38%
Loosely correlated
-8.68%
KRYS - ENTA
38%
Loosely correlated
-2.60%
More